EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

The Future of Cardiovascular Outcomes Trials in Diabetes

Patients with diabetes have an up to 50% increased risk of cardiovascular (CV) disease (CVD) compared to individuals without diabetes. Optimisation of glycaemic control can reduce the long-term development of CVD and mortality. Rafal Ziecina et al. of Worldwide conclude that wider application of digital technology will be required to accelerate the development, testing and delivery of crucial new therapies for patients with CVD.

 

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18